Viewing Study NCT05289856


Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2025-12-25 @ 9:10 PM
Study NCT ID: NCT05289856
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-07
First Post: 2022-03-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)
Sponsor: Johannes Gutenberg University Mainz
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module